PharmaSGP Holding SE (PSG) - Total Liabilities

Latest as of March 2025: €81.51 Million EUR ≈ $95.29 Million USD

Based on the latest financial reports, PharmaSGP Holding SE (PSG) has total liabilities worth €81.51 Million EUR (≈ $95.29 Million USD) as of March 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

PharmaSGP Holding SE - Total Liabilities Trend (2014–2024)

This chart illustrates how PharmaSGP Holding SE's total liabilities have evolved over time, based on quarterly financial data. See PharmaSGP Holding SE short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.

PharmaSGP Holding SE Competitors by Total Liabilities

The table below lists competitors of PharmaSGP Holding SE ranked by their total liabilities.

Company	Country	Total Liabilities
Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A SHG:600613	China	CN¥640.98 Million
Masterwork Machinery SHE:300195	China	CN¥3.48 Billion
Gersan Elektrik Ticaret ve Sanayi AS IS:GEREL	Turkey	TL1.46 Billion
Xiamen Goldenhome Co Ltd SHG:603180	China	CN¥3.24 Billion
Zorlu Enerji Elektrik Uretim AS IS:ZOREN	Turkey	TL73.98 Billion
Hibiscus Petroleum BHD KLSE:5199	Malaysia	RM4.73 Billion
Galata Wind Enerji Anonim Sirket IS:GWIND	Turkey	TL5.36 Billion
Uchi Technologies Bhd KLSE:7100	Malaysia	RM26.26 Million

Liability Composition Analysis (2014–2024)

This chart breaks down PharmaSGP Holding SE's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see PharmaSGP Holding SE market cap and net worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	2.68	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	2.22	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.69	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how PharmaSGP Holding SE's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for PharmaSGP Holding SE (2014–2024)

The table below shows the annual total liabilities of PharmaSGP Holding SE from 2014 to 2024.

Year	Total Liabilities	Change
2024-12-31	€82.31 Million ≈ $96.23 Million	-10.09%
2023-12-31	€91.55 Million ≈ $107.03 Million	-6.60%
2022-12-31	€98.01 Million ≈ $114.59 Million	+5.32%
2021-12-31	€93.06 Million ≈ $108.80 Million	+592.58%
2020-12-31	€13.44 Million ≈ $15.71 Million	+64.65%
2019-12-31	€8.16 Million ≈ $9.54 Million	-63.05%
2017-12-31	€22.09 Million ≈ $25.82 Million	-1.69%
2016-12-31	€22.47 Million ≈ $26.27 Million	-4.22%
2015-12-31	€23.46 Million ≈ $27.42 Million	+16.53%
2014-12-31	€20.13 Million ≈ $23.53 Million	--

About PharmaSGP Holding SE

F:PSG Germany

Market Cap

$387.63 Million

€331.56 Million EUR

Market Cap Rank

#14445 Global

#1443 in Germany

Share Price

€28.80

Change (1 day)

+0.70%

52-Week Range

€28.00 - €29.60

All Time High

€32.32